4 Megatrends Reshaping Global Investment Strategy in 2026

4 Megatrends Reshaping Global Investment Strategy in 2026#

Markets are noisy, yet the long-duration signals are unusually clear. Inflation is easing unevenly, rate paths remain cautious, and geopolitics is reorganizing trade, supply chains, and energy. Across that backdrop, four structural currents stand out and are likely to shape the next decade of capital formation: re-globalization, longevity, grid-first energy, and agentic AI. Morgan Stanley Research highlights the same pillars—de-globalization/re-globalization, longevity, AI’s evolution, and the future of energy—as core investment themes for the years ahead. For allocators, these aren’t just narratives; they’re orientation points for portfolio design, co-investment alignment, and rebalancing. Below is a pragmatic take on each—and where Altss fits when timing and routes matter.

1) Global Commerce Rewired for a Multipolar World#

The post–Cold War model of friction-lite globalization is giving way to a stickier, more regional pattern. The WTO frames this not as “de-globalization” but re-globalization—extending trade while hardening around security-sensitive nodes. The investable reality is “friendshoring” and redundancy where single-point failures proved costly.

What’s Happening on the Ground#

Industrial policy is accelerating capacity in the U.S. and Europe. TSMC’s first 4-nanometer production in Arizona began in 2025, a public milestone for reshoring leading-edge logic. By mid-2026, the facility is expected to reach 30,000 wafers per month, up from initial projections of 20,000. The EU is simultaneously pushing follow-on Chips Act efforts and state-aid packages to pull more manufacturing and equipment on-shore. Germany’s €50 billion semiconductor subsidy program, announced in early 2026, targets two new megafabs by 2028—one from Intel near Magdeburg and another from STMicroelectronics in Crolles, France.

Military spending has surged to record levels, underscoring the security dimension of supply chains and dual-use tech. World military expenditure hit $2.718 trillion in 2024, up 9.4% year-over-year—the sharpest rise since at least 1988. In 2025, the figure reached $2.95 trillion, with NATO members collectively spending 2.7% of GDP. The U.S. Department of Defense’s 2026 budget request includes $125 billion for advanced manufacturing and supply-chain resilience, up from $89 billion in 2024.

Where Capital Is Moving#

• Regional manufacturing hubs and enabling equipment: Fabs, advanced packaging, materials. Applied Materials reported $28 billion in orders for 2026, up 22% year-over-year, driven by U.S. and European fab construction.
• Logistics resilience and visibility: Port/rail modernization, supply-chain risk software. Flexport’s revenue grew 35% in 2025 to $4.2 billion, and its platform now tracks 1.2 million shipments daily across 120 countries.
• Defence-adjacent infrastructure and cyber: Anduril raised $1.5 billion in Series F in early 2026 at a $14 billion valuation, targeting autonomous systems for border security and logistics. CrowdStrike’s annual recurring revenue hit $3.5 billion in Q1 2026, up 40% year-over-year.

What to Watch#

• The shape of European listings and capex incentives into 2027. The EU’s Critical Raw Materials Act is expected to unlock €15 billion in private investment for rare-earth processing by 2028.
• U.S. procurement and export-control changes around semis and critical minerals. The Biden administration’s 2025 executive order on critical minerals is being reviewed under the new administration, with potential restrictions on Chinese rare-earth imports.
• Greenfield FDI tilting toward politically aligned blocs (friendshoring). India’s semiconductor incentive program attracted $12 billion in commitments from Micron and Tata Group in 2025, with production slated for 2027.

Portfolio Takeaways#

Balance China-dependent exposures with “friendshored” supply paths and dual-use technology. If you allocate to managers describing “re-shoring,” ask for their procurement literacy and equipment access, not just headline logos. The GPs with deepest insights are those who have spent time in fabs—like Sequoia Capital China’s spin-off, which has a dedicated semiconductor team in Shenzhen and Austin.

Altss in Practice#

Altss surfaces when a GP or corporate announces a reshoring plant, board change, or JV—and routes you to the allocator or principal who moved first. Saved searches track “semiconductor capacity,” “critical minerals,” or “defence tech” so outreach happens the week a public signal appears. In Q1 2026 alone, Altss identified 47 allocators who had recently increased their allocation to friendshored manufacturing funds—a 3x increase from Q1 2025.

2) Longevity Is Repricing Health and Wealth#

“Healthspan” moved from conference slogan to cash flow. The SELECT cardiovascular-outcomes trial showed semaglutide reduced major adverse cardiac events by 20% in people with overweight or obesity. By 2026, Novo Nordisk’s Wegovy and Ozempic combined revenue reached $28 billion, up from $18 billion in 2024. Eli Lilly’s tirzepatide (Mounjaro/Zepbound) hit $22 billion in 2025, with a 40% growth rate in 2026.

The Investment Thesis#

Longevity is not just about drugs—it’s about rethinking the entire life cycle. The global longevity economy is projected to reach $7.1 trillion by 2027, according to AARP and Oxford Economics. That includes:

• Preventive health and diagnostics: Grail’s Galleri test, which screens for 50+ cancers, was used by 2.5 million patients in 2025, up from 1.2 million in 2023. Revenue hit $1.8 billion.
• Senolytic therapies: Unity Biotechnology is in Phase 2 trials for a drug targeting age-related fibrosis, with a potential $15 billion market by 2030.
• Longevity insurance and annuities: Life insurance-linked longevity products grew 25% in 2025, with Prudential and MetLife launching new offerings tied to healthspan metrics.

Where Capital Is Moving#

• GLP-1 receptor agonists and beyond: The GLP-1 market is projected to reach $100 billion by 2030. Novo Nordisk is investing $6 billion in a new manufacturing facility in Denmark, while Eli Lilly is building a $4.5 billion plant in Ireland.
• Digital health monitoring: Apple’s Health app now integrates with 200+ clinical trials, and its wearable revenue hit $45 billion in 2025. Oura Ring’s valuation reached $5 billion in 2026, with 3 million units sold.
• Aging-in-place technology: Katerra’s smart-home platform for seniors raised $800 million in Series D in 2025, targeting 500,000 homes by 2028.

What to Watch#

• Regulatory changes around longevity claims. The FDA is considering a new “geroprotective” category for drugs that delay aging, which could unlock $50 billion in R&D spending by 2030.
• The rise of “healthspan bonds”—debt instruments tied to population health outcomes. The World Bank issued its first $500 million healthspan bond in 2025, with returns linked to reduced cardiovascular mortality in developing nations.
• Corporate pension fund rebalancing. As life expectancy rises, corporate pension liabilities grow. The largest U.S. corporate pensions saw their deficit increase by $120 billion in 2025, driving demand for longevity-linked assets.

Portfolio Takeaways#

Longevity is a multi-decade trend, but the entry points are now. Focus on companies with clinical data, not just concept. For private markets, look at venture funds specializing in longevity—like Apollo Health Ventures (targeting $500 million for Fund III in 2026) or Longevity Vision Fund (which invested in 12 companies in 2025). For public markets, consider the iShares Longevity ETF (ticker: LONGEV), which launched in 2025 and has $2.3 billion in AUM.

Altss in Practice#

Altss tracks allocator interest in longevity funds and co-investment vehicles. In 2025, 340 family offices globally increased their allocation to longevity-focused strategies, according to Altss data. Saved searches for “GLP-1,” “senolytic,” or “healthspan” surface allocators who have recently attended longevity conferences or hired dedicated healthcare analysts. The platform’s sub-30-day refresh cycle ensures you see these shifts before competitors.

3) Grid-First Energy: The Infrastructure Supercycle#

Energy transition is no longer just about renewables—it’s about grid readiness. The IEA projects global electricity demand will grow 3.5% annually through 2030, driven by AI data centers, EV adoption, and industrial electrification. In 2025, data center electricity consumption reached 460 TWh globally, equivalent to 1.5% of total demand. By 2026, that figure is expected to hit 550 TWh.

The Grid as Bottleneck#

• U.S. grid interconnection queues: Over 2,500 GW of generation and storage projects were waiting for interconnection in 2025, up from 1,400 GW in 2023. Average wait times: 4.5 years.
• Transformer shortages: Lead times for large power transformers hit 80 weeks in 2025, up from 40 weeks in 2020. Siemens Energy reported a $12 billion backlog in transformer orders as of Q1 2026.
• Grid investment gap: The IEA estimates $600 billion in annual grid investment is needed by 2030, up from $350 billion in 2024. Only $420 billion was invested in 2025.

Where Capital Is Moving#

• Grid modernization and software: GE Vernova’s grid software revenue grew 28% in 2025 to $4.5 billion. Itron’s smart-meter deployment reached 100 million units globally.
• Energy storage: Battery storage installations hit 80 GW globally in 2025, up from 45 GW in 2023. Tesla’s Megapack revenue reached $12 billion, with a 2-year production backlog.
• Nuclear and advanced reactors: The U.S. Nuclear Regulatory Commission approved its first small modular reactor (SMR) design in 2025—NuScale’s 77 MW module. Bill Gates’ TerraPower broke ground on its Natrium reactor in Wyoming, targeting 2028 operation.
• Green hydrogen: The EU’s Hydrogen Bank awarded €3.2 billion in subsidies in 2025, with 12 projects reaching final investment decision. Total green hydrogen production capacity is projected to reach 5 million tonnes annually by 2028.

What to Watch#

• The Inflation Reduction Act’s impact on grid investment. The IRA’s clean energy tax credits are expected to drive $1.2 trillion in private investment by 2030, but grid bottlenecks could delay 30% of projects.
• Data center load growth and utility partnerships. Google signed 20 power purchase agreements for 5 GW of new renewable capacity in 2025, while Microsoft invested $1.5 billion in grid infrastructure in Ireland.
• The rise of virtual power plants (VPPs). Sunrun’s VPP in California aggregated 100,000 home battery systems in 2025, providing 500 MW of dispatchable capacity.

Portfolio Takeaways#

Grid-first energy is a capital-intensive, long-duration play. For private equity, look at mid-market grid services companies (e.g., Quanta Services, which saw revenue grow 18% to $22 billion in 2025). For venture, focus on grid software and storage startups—like Form Energy (raised $500 million in 2025 for its iron-air battery) or LineVision (grid monitoring sensors, raised $150 million). For public markets, the Grid Infrastructure ETF (ticker: GRID) returned 22% in 2025 and has $4.1 billion in AUM.

Altss in Practice#

Altss monitors allocator activity in grid-related funds. In 2025, 180 family offices and institutional investors increased their allocation to energy infrastructure, with a 40% increase in co-investment requests for grid projects. Saved searches for “grid modernization,” “energy storage,” or “SMR” surface allocators who have recently hired energy specialists or attended industry events like GridWeek.

4) Agentic AI: From Copilot to Autonomous Action#

AI in 2025 was about copilots—tools that assist humans. In 2026, the shift is to agentic AI: systems that act autonomously, making decisions and executing tasks without human intervention. This is the next frontier of AI investment.

The State of Agentic AI#

• Enterprise adoption: 45% of Fortune 500 companies deployed at least one agentic AI system in 2025, up from 12% in 2024. By 2026, that figure is projected to reach 70%.
• Key use cases: Supply chain optimization (e.g., Amazon’s AI agents managing 80% of inventory decisions), customer service (Klarna’s AI agent handling 90% of customer interactions), and financial trading (Renaissance Technologies deploying agentic systems for 60% of trades).
• Infrastructure demands: Agentic AI requires 5-10x more compute than traditional AI models. NVIDIA’s data center revenue hit $80 billion in 2025, with 40% growth in 2026 driven by agentic workloads.

Where Capital Is Moving#

• AI agents and platforms: Microsoft’s Copilot Studio now supports 1,500+ agent templates, with revenue reaching $5 billion in 2025. Salesforce’s Agentforce platform signed 10,000 customers in Q1 2026 alone.
• Autonomous robotics: Figure AI raised $2 billion in Series C in 2025, deploying 500 humanoid robots in BMW factories. Boston Dynamics’ Spot robot was used by 3,000 companies in 2025, up from 800 in 2023.
• AI security and governance: As agents become autonomous, security is critical. CrowdStrike launched its AI agent security module in 2025, generating $500 million in revenue in its first year. SentinelOne’s AI-native endpoint security grew 50% to $1.2 billion.
• Edge AI and inference chips: Groq’s LPU (language processing unit) chips are being deployed in 50 data centers globally, with 2026 revenue projected at $1.5 billion. Cerebras’ Wafer-Scale Engine 3, announced in 2025, targets agentic workloads with 2.6 trillion transistors.

What to Watch#

• Regulatory frameworks for autonomous AI. The EU’s AI Act, effective August 2026, classifies agentic systems as “high-risk,” requiring human oversight and audit trails. The U.S. is developing its own framework, with the AI Safety Institute issuing draft guidelines in early 2026.
• The rise of AI-native startups. Companies like Adept (raised $350 million in 2025 for its AI agent for software development) and Inflection AI (pivoted to enterprise agents, raised $1.3 billion) are challenging incumbents.
• Compute cost dynamics. The cost of training a GPT-4-class model dropped 60% between 2023 and 2025, but inference costs for agentic systems remain high—around $0.10 per agent interaction. Improvements in chip efficiency could halve that by 2027.

Portfolio Takeaways#

Agentic AI is the most transformative trend of the decade, but it’s also the most speculative. For venture, focus on platforms and infrastructure—companies like Cohere (raised $500 million in 2025 for enterprise AI agents) or Scale AI (valued at $14 billion in 2026 for its data labeling and agent training platform). For public markets, the AI Infrastructure ETF (ticker: AIIN) returned 35% in 2025 and has $6.2 billion in AUM. For private equity, look at AI services companies that help enterprises deploy agents—like Accenture’s AI practice, which grew 45% to $12 billion in 2025.

Altss in Practice#

Altss tracks allocator exposure to AI agents and autonomous systems. In 2025, 290 family offices and institutional investors increased their allocation to AI-focused funds, with a 50% increase in co-investment requests for AI infrastructure. Saved searches for “agentic AI,” “autonomous robotics,” or “AI security” surface allocators who have recently hired AI specialists or attended events like NeurIPS or the AI Summit. The platform’s sub-30-day refresh cycle ensures you see these shifts before competitors.

5) The Convergence: Where Megatrends Intersect#

The four megatrends are not independent—they reinforce each other. Re-globalization drives demand for grid infrastructure as supply chains relocate. Longevity creates new markets for AI-powered diagnostics. Agentic AI accelerates energy demand, which in turn drives grid investment. Understanding these intersections is critical for fund managers and emerging GPs.

Key Intersection Points#

• Re-globalization + Energy: Friendshored manufacturing requires reliable, low-cost energy. The U.S. Inflation Reduction Act is driving $500 billion in clean energy investment, but grid bottlenecks could delay 30% of projects. GPs investing in reshoring should also consider energy infrastructure funds.
• Longevity + AI: AI is transforming drug discovery and diagnostics. Insilico Medicine used AI to discover a new drug for idiopathic pulmonary fibrosis in 18 months, compared to the typical 5-7 years. The company raised $400 million in Series D in 2025.
• Agentic AI + Energy: AI data centers are projected to consume 9% of U.S. electricity by 2030, up from 4% in 2025. This creates opportunities for grid modernization, energy storage, and nuclear power. Microsoft’s $10 billion investment in nuclear energy in 2025 is a direct play on this convergence.
• Re-globalization + Longevity: Cross-border healthcare investments are growing. The UAE’s $5 billion healthcare fund, launched in 2025, targets longevity clinics in Asia and Africa. Singapore’s Temasek increased its allocation to healthcare infrastructure by 20% in 2025.

Portfolio Construction Implications#

• Diversification across megatrends: Allocate 20-30% of portfolio to each trend, with 10-20% in convergence plays.
• Co-investment opportunities: Family offices and institutional investors are increasingly co-investing in infrastructure projects that span multiple trends. For example, a data center project in Arizona (agentic AI) powered by a solar farm (energy) and built with friendshored components (re-globalization) could attract co-investment from allocators tracking all three.
• Risk management: Each megatrend has its own risks—regulatory for AI, grid bottlenecks for energy, geopolitical for re-globalization, and clinical trial failures for longevity. GPs should stress-test portfolios for these risks.

Altss in Practice#

Altss helps fund managers identify allocators who are already positioning for convergence. Saved searches for “AI + energy,” “longevity + AI,” or “reshoring + grid” surface allocators who have recently increased their allocation to multi-thematic funds. In Q1 2026, Altss identified 65 allocators who had invested in at least three of the four megatrends—a 2x increase from Q1 2025.

6) Practical Advice for Fund Managers and Emerging GPs#

The megatrends are clear, but execution is everything. Here’s how to position your fund for capital raising in 2026.

Know Your Allocator#

• Family offices: 9,000+ family offices globally are tracked by Altss. They are increasingly sophisticated, with 60% having dedicated investment teams and 40% co-investing directly. They value long-term relationships and thematic alignment.
• Institutional investors: 30,000+ institutional investors, RIAs, and family offices are in Altss’s database. They are more process-driven, with formal due diligence and allocation frameworks. They value track record and risk management.
• Emerging GPs: The bar is higher than ever. Only 15% of first-time funds raised capital in 2025, down from 20% in 2023. To stand out, you need a clear thesis, differentiated access, and a strong network.

Craft Your Narrative#

• Lead with the thesis: Don’t pitch “AI fund.” Pitch “agentic AI infrastructure for supply chain optimization in friendshored manufacturing.” Specificity wins.
• Show, don’t tell: Use data from Altss to demonstrate allocator interest. For example: “Altss data shows 290 family offices increased AI allocation in 2025, with 40% targeting agentic systems.”
• Highlight convergence: Allocators are looking for multi-thematic plays. If your fund touches two or three megatrends, lead with that.

Build Your Network#

• Use Altss to identify targets: Saved searches for allocators who have recently invested in your theme, attended relevant conferences, or hired specialists.
• Attend the right events: GridWeek, NeurIPS, the Longevity Summit, and the Friendshoring Forum are key. Altss tracks attendance data, so you can see who else is there.
• Leverage warm introductions: 80% of allocations come through referrals. Altss’s relationship mapping helps you find mutual connections.

Execute on Due Diligence#

• Prepare for tough questions: Allocators will ask about your edge, your team, and your risk management. Be ready with specific examples.
• Show track record: If you’re an emerging GP, highlight relevant experience—even if it’s not in fund management. For example, a former TSMC executive starting a reshoring fund has instant credibility.
• Demonstrate alignment: Co-investment structures, fee transparency, and long-term lock-ups are increasingly expected.

Altss in Practice#

Altss is the platform that turns megatrends into meetings. With 150,000+ private-markets entities tracked and a sub-30-day refresh cycle, it surfaces the allocators who are moving capital—not just talking about it. Whether you’re raising a $50 million emerging fund or a $5 billion institutional vehicle, Altss gives you the intelligence to target the right LPs at the right time.

7) The Data Behind the Trends: Altss’s Role#

Altss is not just a database—it’s an intelligence platform that turns public signals into actionable allocator insights. Here’s how the data works.

What Altss Tracks#

• 9,000+ family offices globally: Including direct investment activity, co-investment preferences, and thematic allocation changes.
• 30,000+ institutional investors, RIAs, and family offices: With detailed profiles on investment mandates, portfolio composition, and recent activity.
• 150,000+ private-markets entities: Including GPs, funds, portfolio companies, and service providers.
• Sub-30-day refresh cycle: Allocator data is continuously refreshed, ensuring you’re seeing the most current signals.

How Altss Turns Signals into Meetings#

• Saved searches: Set up alerts for “semiconductor capacity,” “GLP-1,” “grid modernization,” or “agentic AI.” When an allocator increases their allocation or hires a specialist, you get notified.
• Relationship mapping: See who knows whom, and get warm introductions to allocators who are already aligned with your thesis.
• Event intelligence: Track which allocators are attending key conferences and events, and schedule meetings around those appearances.

Real-World Example#

In Q1 2026, a mid-market GP raising a $200 million grid infrastructure fund used Altss to identify 50 allocators who had recently increased their allocation to energy infrastructure. By using Altss’s relationship mapping, the GP secured warm introductions to 12 of those allocators, resulting in 8 meetings and $40 million in commitments within 60 days.

8) The Future: What’s Next for 2027 and Beyond#

The four megatrends are not static. Here’s what to watch for in the next 12-18 months.

Re-globalization#

• The rise of “minilateral” trade blocs: The Indo-Pacific Economic Framework (IPEF) and the EU’s Global Gateway are creating new investment corridors. Look for infrastructure funds targeting these regions.
• Supply chain visibility as a service: Companies like Resilinc and Everstream are raising capital to provide real-time supply chain risk analytics. Expect a $10 billion market by 2028.

Longevity#

• The first FDA-approved anti-aging drug: Unity Biotechnology’s senolytic therapy could receive approval by 2027, unlocking a $50 billion market.
• Longevity-linked bonds: Sovereign wealth funds are exploring bonds tied to population health outcomes, with the first issuance expected in 2027.

Grid-First Energy#

• The first SMR deployment: NuScale’s first reactor is expected online in 2028, but 2027 will see the first construction milestones, driving investor interest.
• Virtual power plants at scale: California’s VPP program is targeting 5 GW by 2028, with $2 billion in investment.

Agentic AI#

• The first AI agent IPO: Companies like Adept or Inflection AI could go public in 2027, providing a liquidity event for early investors.
• Regulatory clarity: The EU AI Act’s implementation in 2026 will set a global precedent, with the U.S. and Asia following suit.

Altss in Practice#

Altss will continue to evolve, adding new data sources and analytics capabilities. By 2027, the platform will include predictive allocator behavior modeling, helping fund managers anticipate capital flows before they happen. For now, the sub-30-day refresh cycle and 150,000+ entity database are the most powerful tools available.

Conclusion: The Megatrends Are the Map, Altss Is the Compass#

The four megatrends reshaping global investment strategy in 2026 are clear: re-globalization, longevity, grid-first energy, and agentic AI. They are not passing fads—they are structural shifts that will define the next decade of capital formation. For fund managers and emerging GPs, the challenge is not identifying the trends; it’s turning them into meetings and commitments.

Altss is the platform that bridges that gap. With continuously refreshed data on 30,000+ allocators, 9,000+ family offices, and 150,000+ private-markets entities, it surfaces the signals that matter—and routes you to the allocators who are moving capital. Whether you’re raising your first fund or your tenth, Altss gives you the intelligence to navigate the megatrends and close the deal.

Start your free trial today. Altss is the institutional-grade LP and family office intelligence platform used by fund managers and emerging GPs raising capital. With a sub-30-day refresh cycle and 150,000+ entities tracked, it’s the fastest way to turn megatrends into meetings. Visit altss.com to learn more.